Skip to main content
SpineGuard logo

SpineGuard — Investor Relations & Filings

Ticker · ALSGD ISIN · FR0011464452 LEI · 969500Z4BRXQX6CSL565 PA Manufacturing
Open in API
Filings indexed 466 across all filing types
Latest filing 2025-03-12 Capital/Financing Update
Country FR France
Listing PA ALSGD

About SpineGuard

https://www.spineguard.com/

SpineGuard is a medical technology company that develops and markets the proprietary Dynamic Surgical Guidance (DSG) technology. DSG is a radiation-free, real-time sensing platform designed to make spine surgery safer. The technology is embedded in the company's PediGuard family of smart drilling instruments, which assist surgeons in the accurate placement of skeletal implants, particularly pedicle screws. By differentiating tissue types at the instrument's tip, the devices provide audible and visual feedback to help anticipate potential breaches of the vertebral wall, thereby enhancing procedural safety and accuracy. SpineGuard's primary goal is to establish DSG as a standard of care for securing and streamlining skeletal implant placement.

Recent filings

Filing Released Lang Actions
Acquisition ou cession des actions de l'émetteur / Transactions sur actions propres (version agrégée)
Capital/Financing Update Classification · 99% confidence The document explicitly announces the launch of a capital increase ('augmentation de capital') with preferential subscription rights ('maintien du droit préférentiel de souscription des actionnaires'). It details the subscription price, parity, subscription periods, and the intended use of the funds. This content directly relates to fundraising, financing activities, and changes in the capital structure. Therefore, the appropriate classification is Capital/Financing Update (CAP). It is not an ER (too detailed), an IR (not a comprehensive periodic report), or an RPA (it is the primary announcement of the event, not just an announcement of a report).
2025-03-12 French
Acquisition ou cession des actions de l'émetteur / Information relative au contrat de liquidité
Regulatory Filings Classification · 99% confidence The document is titled "Bilan semestriel du contrat de liquidité contracté avec la société de bourse TSAF" (Semi-annual balance sheet of the liquidity contract concluded with the brokerage firm TSAF) and reports on the status and transactions of a liquidity contract as of 31/12/2024, comparing it to the previous semi-annual balance (30/06/2024). This type of regular, periodic disclosure related to market making or share stabilization activities, especially when presented as a formal balance/report, aligns best with disclosures concerning share transactions or capital structure management. Since it details the activity of a liquidity contract (which involves buying and selling shares), it is highly related to the company's own share transactions. The category 'Transaction in Own Shares' (POS) covers reports of the company buying back or selling its own shares. While this is specifically about a liquidity contract, the underlying activity is share trading by a designated agent on behalf of the company, making POS the most appropriate fit among the provided options, as it is a specific report detailing share transactions, not just a general announcement (RPA/RNS). It is not a full Annual Report (10-K) or an Interim Report (IR) as it focuses narrowly on the liquidity contract.
2025-02-12 French
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is a press release from SpineGuard announcing the commercial launch of a new medical device (PsiFGuard) in partnership with Omnia Medical. It includes quotes from management, a 2025 outlook, and company background information. As it is a general corporate announcement regarding business operations and product launches that does not fit into specific financial reporting categories like 10-K, ER, or IR, it is classified as a general regulatory filing/announcement.
2025-02-10 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release from SpineGuard announcing the commercial launch of a new medical device ('PsiFGuard') developed in partnership with Omnia Medical. It includes quotes from management, details about the product, and a section on 2025 business perspectives. As it is a general corporate announcement regarding business operations and product launches that does not fit into specific financial reporting categories like 10-K or IR, it is classified as a Regulatory Filing (RNS).
2025-02-10 French
Informations privilégiées / Information sur chiffre d’affaires annuel
Earnings Release Classification · 100% confidence The document is titled "SpineGuard annonce son chiffre d'affaires annuel 2024" (SpineGuard announces its 2024 annual revenue) and provides a detailed breakdown of revenue figures for the full 12 months ending December 31, 2024, comparing them to 2023. It includes quarterly breakdowns and commentary on business performance. This content structure is characteristic of an Earnings Release (ER), which announces periodical financial results (key highlights). Although it contains detailed figures, it is presented as an announcement dated January 10, 2025, summarizing the *past* fiscal year, making it an initial release of results rather than the comprehensive Annual Report (10-K) or a Management Discussion & Analysis (MDA). Since it focuses on the top-line revenue announcement for the period, ER is the most appropriate classification. FY 2024
2025-01-10 French
Inside Information / Information on annual revenues
Earnings Release Classification · 100% confidence The document is titled "SpineGuard Reports its full-year 2024 Revenue" and presents consolidated revenue figures for the full year 2024 compared to 2023, broken down by quarter and geography. It includes key financial highlights, management commentary on performance, and an outlook for 2025. This content structure—reporting period results, key metrics, and management discussion—is characteristic of an Earnings Release (ER). It is not a comprehensive Annual Report (10-K) or a detailed Interim Report (IR), as it focuses specifically on revenue for the full year and is presented as an initial announcement. FY 2024
2025-01-10 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.